Abstract
Sub-clinical organ damage is a strong independent predictor of cardiovascular mortality in primary hypertension, and its changes over time parallel those in risk of cardiovascular events. A better understanding of the pathogenetic mechanisms underlying the development of target organ damage may help us devise more effective therapeutic strategies. We therefore investigated the relationship between the presence of organ damage and some of its potential determinants, such as blood pressure severity and early atherosclerotic abnormalities. Thirty-seven untreated, non-diabetic hypertensive patients were enrolled. Target organ damage was assessed by albuminuria and left ventricular mass index; systemic vascular permeability was evaluated by transcapillary escape rate of albumin (TERalb); and blood pressure was measured by 24-h ambulatory blood pressure monitoring. The albumin-to-creatinine ratio and left ventricular mass index were directly related to TERalb (r=0.48, p=0.003 and r=0.39, p<0.020, respectively) and 24-h systolic blood pressure values (r=0.54, p<0.001; r=0.60, p<0.001). The simultaneous occurrence of increased blood pressure load and TERalb was associated with higher left ventricular mass index values (p=0.012) and entailed an increased risk of having at least one sign of damage (χ2=17.4; p<0.001). Logistic regression analysis showed that the risk of presenting at least one sign of organ damage increased more than ten-fold when TERalb was above the median and more than five-fold with each 10 mmHg increase in 24-h systolic blood pressure. Blood pressure load and vascular permeability are potentially modifiable factors that are independently associated with the occurrence of sub-clinical signs of renal and cardiac damage in hypertensive patients.
Similar content being viewed by others
Article PDF
References
European Society of Hypertension−European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension−European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–178.
Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS : The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117: 831–836.
Gardin JM, McClelland R, Kitzman D, et al: M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol 2001; 87: 1051–1057.
Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K : Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898–903.
Wachtell K, Ibsen H, Olsen MH, et al: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901–906.
Hillege HL, Fidler V, Diercks GF, et al, Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777–1782.
Olsen MH, Wachtell K, Ibsen H, et al, LIFE Study Investigators : Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study. J Hypertens 2006; 24: 775–781.
Ibsen H, Olsen MH, Wachtell K, et al: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198–202.
Pedrinelli R, Penno G, Dell'Omo G, et al: Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. Hypertension 1998; 32: 318–323.
Pontremoli R, Sofia A, Ravera M, et al: Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Hypertension 1997; 30: 1135–1143.
Friedewald WT, Levi RI, Fredrickson DJ : Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499–502.
Cockcroft DW, Gault MH : Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.
De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH : Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056–1062.
Dupont WD, Plummer WD Jr : Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11: 116–128.
Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E : Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5: 180–186.
Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS : Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994; 12: 947–953.
Fesler P, Ribstein J, du Cailar G, Mimran A : Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects. Kidney Int 2005; 67: 1974–1979.
Cuspidi C, Meani S, Fusi V, et al: Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005; 19: 471–477.
Benjamin EJ, Levy D : Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci 1999; 317: 168–175.
Ganau A, Devereux RB, Pickering TG, et al: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25–36.
Viazzi F, Leoncini G, Ratto E, et al: Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens 2006; 19: 1183–1189.
Cottone S, Mule G, Nardi E, et al: Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21: 167–172.
Sciacqua A, Scozzafava A, Pujia A, et al: Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur Heart J 2005; 26: 921–927.
Feldt-Rasmussen B : Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986; 290: 282–286.
Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE : Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002; 25: 2328–2334.
Pedrinelli R, Penno G, Dell'Omo G, et al: Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension 1999; 34: 491–495.
Rocha R, Stier CT Jr : Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001; 12: 308–314.
Baldoncini R, Desideri G, Bellini C, et al: High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients. Kidney Int 1999; 56: 1499–1504.
Schillaci G, Pirro M, Pucci G, et al: Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 2006; 47: 881–886.
Schillaci G, Vaudo G, Reboldi G, et al: High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265–2270.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Viazzi, F., Leoncini, G., Ratto, E. et al. Vascular Permeability, Blood Pressure, and Organ Damage in Primary Hypertension. Hypertens Res 31, 873–879 (2008). https://doi.org/10.1291/hypres.31.873
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.873
Keywords
This article is cited by
-
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
Basic Research in Cardiology (2020)
-
Elevated blood pressure and illness beliefs: a cross-sectional study of emergency department patients in Jamaica
International Journal of Emergency Medicine (2018)